drugset / Trial / NCT07033182
Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment
Phase 1
Completed
24 enrolled
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
The First Affiliated Hospital of Zhengzhou University · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the pharmacokinetics and safety of a single intravenous dose of levornidazole disodium phosphate for injection in subjects with moderate and severe renal impairment and healthy subjects.
Timeline
- Start
- 2023-10-30
- Primary completion
- 2024-04-07
- Completion
- 2024-06-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levornidazole | Unknown | — | Intravenous |